Enhancing Diagnosis and Prevention of Cardiovascular Disease in Newham by Integrated Use of Electronic Health Records

Cardiovascular Disease Clinical Trial

Official title:

Enhancing the Diagnosis and Prevention of Cardiovascular Disease in Newham by Integrated Use of Electronic Health Records

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02486913
• Other study ID #: MCPH1C8R
• Status: Completed
• Phase: N/A
• First received: June 16, 2015
• Last updated: March 5, 2018
• Start date: August 2015
• Est. completion date: January 1, 2018

Study information

• Verified date: February 2017
• Source: Queen Mary University of London
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The investigators will develop a "risk report" within the primary care electronic health record (EMIS) for patients attending for their National Health Service Health Check. The value of the report for reducing cardiovascular risk will be assessed qualitatively and also quantitatively in a non-randomised comparative trial.

Description:

The investigators will design a template within the primary care electronic health record (EMIS) that draws on Health Check data to provide a contemporary "risk report". Included in the report will be clear description of life-time cardiovascular risks, the factors driving those risks and how risk might be reduced through life-style and risk factor modification. The investigators will evaluate the benefits of providing patients with a risk report qualitatively by patient and clinician interviews. Quantitative analysis of the benefit of the risk report will be provided by a non-randomised comparative trial. First, a group of patients undergoing a conventional Health Check will be recalled after three months for a second Health Check, allowing measurement of the change in "Heart Age" - a convenient index of life-time cardiovascular risk. Following introduction of the risk report the investigators will recall a further group of patients for a second Health Check, allowing measurement of the change in "Heart Age". The effect of the risk report will be determined by comparing the change in Heart Age between the two groups of patients.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 190
• Est. completion date: January 1, 2018
• Est. primary completion date: January 1, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 40 Years to 74 Years

Eligibility

Inclusion Criteria:

• Adults aged 40-74 years

Exclusion Criteria:

• Prior diagnosis of heart disease, stroke, diabetes, kidney disease or dementia

Related Conditions & MeSH terms

• Cardiovascular Disease
• Cardiovascular Diseases

Intervention

Other:
• Enhanced Health Check
National Health Service Health Check enhanced by risk report

Locations

Country	Name	City	State
United Kingdom	Bart's Heart Centre	London

Sponsors (1)

Lead Sponsor	Collaborator
Queen Mary University of London

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in Heart Age	Change in Heart Age between 1st Health Check and 2nd Health Check three months later	3 months
Secondary	Changes in smoking status	Changes in smoking status (number smoked per day) by direct patient enquiry between 1st Health Check and 2nd Health Check three months later.	3 months
Secondary	Change in total cholesterol	Changes in total blood cholesterol (mmol/L) by serum sampling between 1st Health Check and 2nd Health Check three months later.	3 months
Secondary	Change in systolic blood pressure	Change in systolic blood pressure (mmHg) by direct measurement using an inflatable cuff between 1st Health Check and 2nd Health Check three months later.	3 months
Secondary	Change in body mass index	Change in body mass index by measurement of height and weight between 1st Health Check and 2nd Health Check three months later.	3 months

External Links

•   NHS Health Check Home Page